Last reviewed · How we verify
NCT05344352
Effect of a Multistrain Probiotic on Allergic Rhinitis Symptoms and Gut Microbiota Composition in Atopic Patients
NA trial testing Multistrain Probiotic in Allergic Rhinitis in 60 participants. Completed in 30 June 2024.
31 December 2023
Quick facts
| Lead sponsor | Università degli Studi di Ferrara |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 30 March 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Multistrain Probiotic
- Placebo
Conditions studied
- Allergic Rhinitis — all drugs for Allergic Rhinitis →
Sponsor
Università degli Studi di Ferrara — full company profile →
Who can join
Adults 18 to 60, any sex, with Allergic Rhinitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the current study is to evaluate the efficacy of administering a multistrain probiotic in adult human subjects suffering from allergic rhinitis and evaluate both symptomatology through validated questionnaires and gut microbiota modification during and after treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial.
Lungaro L, Malfa P, Manza F, Costanzini A, et al · · 2024 · cited 12× · PMID 39683566 · DOI 10.3390/nu16234173
Verify or expand the search:
- PubMed search for NCT05344352
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multistrain Probiotic
Trials testing the same drug.
- NCT06284577 — Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis · NA · recruiting
- NCT06088940 — The Chemo-Gut Probiotic Trial for Cancer Survivors · NA · unknown
Other recruiting trials for Allergic Rhinitis
Currently open trials in the same condition.
- NCT07453615 — Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children · NA · recruiting
- NCT07419230 — Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project · NA · recruiting
- NCT06960382 — Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Ast · Phase 1, PHASE2 · recruiting
- NCT07455968 — Free Diving Breathing Training in Allergic Rhinitis · NA · active not recruiting
- NCT07115342 — Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis · NA · recruiting
Other Università degli Studi di Ferrara trials
Trials by the same sponsor.
- NCT07157696 — Advanced Respiratory Monitoring and Oxygen Therapy in Chronically Ill Patients With Acute Respiratory Failure · NA · not yet recruiting
- NCT06671106 — Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis i · NA · recruiting
- NCT06482294 — CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma · Phase 2 · active not recruiting
- NCT06215001 — Individualized Selection of PEEP in Patients Affected by Expiratory Flow Limitation · NA · unknown
- NCT06769308 — Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05344352 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Università degli Studi di Ferrara
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05344352.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing